August 10, 2023 — Blackford, the pioneering strategic imaging AI platform and solutions provider, and AI4MedImaging, a cardiac MRI solution provider announce a partnership to make the AI4CMR solution available on the Blackford Platform. AI4CMR will enable Blackford customers to automatically segment and quantify cardiac MRI measurements. 

August 10, 2023 — It is the position of SCAI that ABIM diplomates who successfully pass their exams and report procedural volumes in a timely fashion should be indisputably recognized as “certified” for the respecti

August 10, 2023 — Cardiovascular disease is the number one killer of all Americans. Yet, African Americans are 30% more likely to die from heart disease than non-Hispanic whites. 

Having high levels of low-density lipoprotein, or LDL (what some call "bad cholesterol"), is a well-known risk factor for cardiovascular disease, but a less-known risk may involve high levels of a particle called lipoprotein(a), also known as "Lp little a." 

August 10, 2023 — Cleerly, an artificial intelligence (AI) digital healthcare company, recently announced it was named “Best Overall AI Solution” in the sixth annual AI Breakthrough Awards program conducted by AI Breakthrough, a leading market intelligence organization that recognizes the top companies, technologies and products in the global Artificial Intelligence (AI) market.

As medical advancements continue to push the boundaries of what is possible in the field of structural heart interventions, the importance of enterprise imaging has become increasingly evident.

Maureen Gardner has worked in clinical cardiology for over 40 years, with experience and participation in many industry innovations and developments. She joined Change Healthcare in 2011 after a successful career in the NHS in both invasive and non-invasive cardiology, and is now a Senior Clinical Product Manager for cardiovascular solutions.

August 9, 2023 — A joint statement by two medical associations has been issued on a new guideline for the treatment of chronic coronary disease. It notes that for the more than 20 million people in the U.S. with chronic coronary disease, a heart-healthy diet and lifestyle are the best ways to prevent worsening health.

August 9, 2023 — A team of researchers, led by the Hebrew University of Jerusalem (HU), has developed a tiny human heart model that could potentially transform cardiovascular research and animal-free drug testing. 

August 9, 2023 — Novo Nordisk announced the headline results from the SELECT cardiovascular outcomes trial. The double-blinded trial compared subcutaneous once-weekly semaglutide 2.4 mg with placebo as an adjunct to standard of care for prevention of major adverse cardiovascular events (MACEs) over a period of up to five years.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now